Search Results 1031-1040 of 19905 for Receptor
receptors (eg, 4-1BB, OX40) - Cohort B only: - Known history of Grade 3 or higher immune-related adverse events (irAEs) that led to treatment ...
Lacy BE, Cangemi DJ. Opioids and the Gastrointestinal Tract: The Role of Peripherally Active micro-Opioid Receptor Antagonists in Modulating Intestinal ...
Mouse models of FOP have demonstrated the ability of retinoic acid receptor gamma (RARγ) agonists such as palovarotene to prevent HO following injury. This ...
No ua\se of GnRH analogues, aromatase inhimitors, selective E2 or P4 receptor modulators, oral contraceptives, or immunotherapy within 3 months prior to ...
inhibitors and GLD-1 receptor agonists. So, both of those groups of drugs, so there is lots of lots of data, very strong scientific evidence proving that ...
... receptor-positive, HER2+ metastatic breast cancer. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
Chimeric antigen receptor therapy (CAR-T cell therapy) uses a patient's own immune cells to treat cancer. CAR-T cell therapy has been approved by the Food ...
... receptor (PPAR)γ agonists (pioglitazone or rosiglitazone). For pre-existing antidiabetic treatment, subjects should be on a stable dose of antidiabetic ...
Estrogen receptor (ER)/progesterone receptor (PR)-negative (≤ 5% cells) by immunohistochemistry (IHC) and human epidermal grow (HER2) negative (by IHC or ...
Observations from the Ting lab and others over the past decade have shown this to be due to the presence of a cell death checkpoint early in the TNF receptor ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.